亚洲知识产权资讯网为知识产权业界提供一个一站式网上交易平台,协助业界发掘知识产权贸易商机,并与环球知识产权业界建立联系。无论你是知识产权拥有者正在出售您的知识产权,或是制造商需要购买技术以提高操作效能,又或是知识产权配套服务供应商,你将会从本网站发掘到有用的知识产权贸易资讯。

Slow Release Drug Conjugates for Local Eye Therapy for Diseases

详细技术说明
University researchers have invented an approach to develop compounds the use of which would lessen the need for surgical placement and replacement of intravitreal implants for treating chronic vitreoretinal diseases. Frequent injections of therapies can lead to retinal detachment and endophthalmitis, and are extremely inconvenient to the patient. By developing a compound that has the property of being intravitreally injectable and long-acting, University researchers have come up with a way to administer therapy to the eye that does not require surgery or frequent injections. Animal studies have confirmed that the half-life of a therapeutic may be extended to between 8 to 20 weeks, or more.
*Abstract
None
*IP Issue Date
Sep 13, 2011
*Principal Investigation

Name: Lingyun Cheng

Department:


Name: William Freeman

Department:


Name: Karl Hostetler

Department:

附加资料
Patent Number: US8017135B1
Application Number: US2004770885A
Inventor: Hostetler, Karl Y. | Freeman, William R. | Cheng, Lingyun
Priority Date: 31 Jan 2003
Priority Number: US8017135B1
Application Date: 2 Feb 2004
Publication Date: 13 Sep 2011
IPC Current: A61K000900
US Class: 424400 | 514110
Assignee Applicant: The Regents of the University of California
Title: Lipid-drug conjugates for local therapy of eye diseases
Usefulness: Lipid-drug conjugates for local therapy of eye diseases
Summary: The method is useful for treating: HSV-1 and CMV retinitis (claimed); and inappropriate proliferation of vascular tissues in the chamber of eye e.g. wet form of senile macular degeneration and diabetic proliferative retinopathy. Tests details are described but no results given.
Novelty: Treating herpes simplex virus-1 or cytomegalo virus retinitis comprises intravitreally injecting a suspension of 1-O-hexadecylcycloxypropyl-cyclic-cidofovir particles or hexadecyloxypropyl-3-phosphoganciclovir particles to the eye
主要类别
诊断/治疗
细分类别
其他疾病
申请号码
8017135
其他

Tech ID/UC Case

19662/2003-113-0


Related Cases

2003-113-0

国家/地区
美国

欲了解更多信息,请点击 这里
移动设备